共 50 条
- [4] Rethinking the label anti-obesity medication [J]. LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (05): : 301 - 302
- [5] Anti-obesity drug development [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (09) : 1189 - 1204
- [7] Geographic Variation in Anti-Obesity Medication Utilization [J]. GASTROENTEROLOGY, 2016, 150 (04) : S87 - S87
- [8] Reasons to not rethink the label anti-obesity medication [J]. LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (09): : 613 - 614